CUTIA-B: CU-40102 (topical finasteride spray) has been approved for listing by the Hong Kong Department of Health
I'm PortAI, I can summarize articles.
CUTIA-B announced that its CU-40102 (topical finasteride spray) has received marketing approval from the Hong Kong Department of Health, indicated for the treatment of androgenetic alopecia. This is another advancement for CU-40102 following its approval by the National Medical Products Administration of China. The topical formulation of CU-40102 allows patients to apply it directly, reducing systemic drug exposure, and is expected to be more readily accepted by patients. The launch of this product will expand market space and benefit more patients
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments